Stay updated on Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial
Sign up to get notified when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.

Latest updates to the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study criteria and descriptions related to a Phase 2 clinical trial for Growth Hormone-Deficiency, while adding a new EudraCT number and a revision number update.SummaryDifference17%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check51 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check73 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.